Lopinavir and ritonavir and Darunavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lopinavir and ritonavir and Darunavir. Common interactions include maternal exposure during pregnancy among females and diplopia among males.

The phase IV clinical study analyzes what interactions people who take Lopinavir and ritonavir and Darunavir have. It is created by eHealthMe based on reports of 14 people who take Lopinavir and ritonavir and Darunavir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 19, 2022

14 people who take Lopinavir and ritonavir and Darunavir together, and have interactions are studied.


What is Lopinavir and ritonavir?

Lopinavir and ritonavir has active ingredients of lopinavir;ritonavir. eHealthMe is studying from 158 Lopinavir and ritonavir users for its effectiveness, alternative drugs and more.

What is Darunavir?

Darunavir has active ingredients of darunavir. eHealthMe is studying from 5,435 Darunavir users for its effectiveness, alternative drugs and more.

Number of Lopinavir and ritonavir and Darunavir reports submitted per year:

Lopinavir and ritonavir and Darunavir drug interactions.

Common Lopinavir And Ritonavir and Darunavir drug interactions by gender *:

female:

  1. Maternal exposure during pregnancy
  2. Sinus bradycardia

male:

  1. Diplopia
  2. Eyelid ptosis
  3. Lipodystrophy acquired
  4. Mitochondrial toxicity
  5. Progressive external ophthalmoplegia
  6. Extraocular muscle paresis
  7. Ophthalmoplegia
  8. Pathogen resistance
  9. Atrial flutter
  10. Foetal exposure during pregnancy

Common Lopinavir And Ritonavir and Darunavir drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Maternal exposure during pregnancy

30-39:

  1. Sinus bradycardia

40-49:

n/a

50-59:

  1. Diplopia
  2. Eyelid ptosis
  3. Lipodystrophy acquired
  4. Mitochondrial toxicity
  5. Progressive external ophthalmoplegia
  6. Extraocular muscle paresis
  7. Ophthalmoplegia
  8. Atrial flutter

60+:

n/a

Common conditions people have *:

  1. Hiv Infection: 9 people, 64.29%

* Approximation only. Some reports may have incomplete information.

Do you take Lopinavir and ritonavir and Darunavir?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Lopinavir and ritonavir and Darunavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Darunavir interactions:

Browse all interactions between Darunavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lopinavir;ritonavir and darunavir (the active ingredients of Lopinavir and ritonavir and Darunavir, respectively), and Lopinavir and ritonavir and Darunavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lopinavir and ritonavir and Darunavir.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: